Press releases
- Bio-Rad to Report Second Quarter Financial Results on Thursday, August 1, 2024
- Bio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group
- Bio-Rad’s Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference
- Bio-Rad Reports First-Quarter 2024 Financial Results
- Bio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference
- Bio-Rad Announces Life Science Group Management Changes
More ▼
Key statistics
As of last trade, Bio Rad Laboratories Inc (BUWA:BER) traded at 270.30, 10.55% above the 52 week low of 244.50 set on Jul 02, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 270.30 |
---|---|
High | 270.30 |
Low | 270.30 |
Bid | 270.50 |
Offer | 275.40 |
Previous close | 273.30 |
Average volume | 16.29 |
---|---|
Shares outstanding | 28.52m |
Free float | 19.99m |
P/E (TTM) | -- |
Market cap | 8.91bn USD |
EPS (TTM) | -10.36 USD |
Data delayed at least 15 minutes, as of Jul 22 2024 07:08 BST.
More ▼